Peter Jay Hotez, MD, PhD


  • Texas Medical Center

Phone: 832-824-1000

Contact Information

Feigin Center
1102 Bates Street, 5th Floor
Houston, TX 77030
United States
Texas US

Director, Center for Vaccine Development

Texas Children's Hospital

Endowed Chair in Tropical Pediatrics, Texas Children's Hospital

Dean for the National School of Tropical Medicine, Baylor College of Medicine

Professor, Departments of Pediatrics and Molecular Virology & Microbiology, Baylor College of Medicine

Faculty Fellow, Hagler Institute for Advanced Study at Texas A&M University, College Station, TX

University Professor, Department of Biology, Baylor University, Waco, TX


School Education Degree Year
Weill Cornell Medical College, New York, NY medical school Medical Doctor 1987
The Rockefeller University, New York, NY PhD Doctor of Philosophy 1986


Professional Interests:

Vaccine Development
Tropical Medicine


Coronavirus Vaccine Development Program - COVID-19 is a highly transmissible with an estimated reproductive number (R0) of 2.2, a mean incubation period of 5.8 days and transmitted from infected individuals with or without symptoms. High transmissibility means that the control of this viral infection will be challenging without the prospect of a vaccine.

Human Hookworm Vaccine Initiative - Texas Children's Hospital Center for Vaccine Development - Development of a vaccine for the more than 400 million people suffering from hookworm infection in the world today. Vaccine currently in phase 1 clinical trials in Brazil and Gabon.

Schistosomiasis Vaccine Initiative - Texas Children's Hospital Center for Vaccine Development - Schistosomiasis afflicts over 200 million people around the globe and is the deadliest disease among the seven most prevalent NTDs, killing an estimated 280,000 people annually. Our vaccine is entering phase 1 clinical trials.

Chagas Disease and Leishmaniasis Vaccine Initiatives - Texas Children's Hospital Center for Vaccine Development - A project for the selection and discovery of antigens appropriate to advance into the development process of new vaccines to combat Chagas disease (American trypanosomiasis) and leishmaniasis.

SARS Vaccine Development Program - Texas Children's Hospital Center for Vaccine Development - A new vaccine to prevent severe acute respiratory syndrome (SARS). A prototype RBD219 N1 vaccine is entering scale-up process development

Multivalent Anthelmintic Vaccine Discovery Program - Texas Children's Hospital Center for Vaccine Development - A panhelmintic vaccine to prevent ascariasis (roundworm) and trichuris (whipworm), soil-transmitted helminths afflicting hundreds of millions of people around the world

View News Articles:


Organization Name Role
James A. Baker III Institute for Public Policy, Rice University, Houston, TX Fellow in Disease and Poverty
PLOS Neglected Tropical Diseases Founding Editor in Chief